Related Experiment Videos
Polyurethanes based on dihydroxamic acids. Synthesis, chemical characterization, and biological activity
T Buruiana1, D Spridon, E C Buruiana
1P. Poni Institute of Macromolecular Chemistry, Aleea Grigore Ghica Voda, Iassy, Romania.
Journal of Biomaterials Science. Polymer Edition
|December 22, 1999
Summary
New biocompatible polyurethanes show promising antitumoral activity. Researchers found that the structure of dihydroxamic acid and polyethylene oxide content significantly influenced the cancer-fighting properties in vivo.
Area of Science:
- Polymer Chemistry
- Biomedical Materials Science
- Pharmacology
Background:
- Segmented polyurethanes are versatile biomaterials.
- Dihydroxamic acids offer unique chemical functionalities.
- Developing novel materials with enhanced biological properties is crucial.
Purpose of the Study:
- To synthesize and characterize novel segmented polyurethanes.
- To evaluate the biocompatibility and antitumoral activity of these polymers.
- To investigate the influence of dihydroxamic acid structure and polymer composition on biological outcomes.
Main Methods:
- Synthesis of segmented polyurethanes using polyethylene oxide/polycaprolactone diol, isophorone diisocyanate, and dihydroxamic acids.
- In vivo testing for biocompatibility in Wistar male rats.
- In vivo evaluation of antitumoral activity against Walker 256 carcinosarcoma in Wistar rats.
- In vitro biodegradation studies.
Main Results:
- Polyurethanes containing aliphatic dihydroxamic acid segments demonstrated superior antitumoral activity compared to those with terephthaloyl dihydroxamic acid.
- Increased polyethylene oxide content in the polymer chain correlated with enhanced antitumoral efficacy.
- Biocompatibility and biodegradation were also assessed.
Conclusions:
- The chemical structure of dihydroxamic acid significantly impacts the antitumoral properties of segmented polyurethanes.
- Polyethylene oxide content is a key factor in modulating antitumoral activity.
- These novel polyurethanes show potential as biocompatible antitumoral agents.